Immunotherapy for a POLE Mutation Advanced Non-Small-Cell Lung Cancer Patient
Currently, the predictive role of POLE mutations for immunotherapy is under intense investigation. The POLE gene encodes one of the four subunits of DNA polymerase important for DNA replication and repair. POLE mutations are related to other favorable predicative factors such as high expression of P...
Saved in:
Main Authors: | Yang Fu (Author), Yue Zheng (Author), Pei-Pei Wang (Author), Yue-Yun Chen (Author), Zhen-Yu Ding (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancer
by: Yue Pan, et al.
Published: (2022) -
Current status of immunotherapy for non-small cell lung cancer
by: Tao Yang, et al.
Published: (2022) -
PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY
by: A. V. Rudakova, et al.
Published: (2017) -
First line Immunotherapy for Non-Small Cell Lung Cancer
by: Nicola J. Nasser, et al.
Published: (2020) -
EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives
by: Jiabao Hou, et al.
Published: (2022)